SCHEMBL31450794

SCHEMBL31450794

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CN(CCCCCCC(=O)O)C5)c(S(=O)(=O)C(F)(F)F)c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.83

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.83
▸ BCL2L1 Q07817 2/20 0.70
▸ MCL1 Q07820 2/20 0.70
▸ BCL2L2 Q92843 2/20 0.70
▸ NSD2 O96028 1/20 0.70
▸ ADORA3 P0DMS8 1/20 0.70
▸ CYP2C9 P11712 1/20 0.70
▸ ADRA2C P18825 1/20 0.70
▸ SLC6A2 P23975 1/20 0.70
▸ BID P55957 1/20 0.70
▸ SLC6A3 Q01959 1/20 0.70
▸ ASPH Q12797 1/20 0.70
▸ BAD Q92934 1/20 0.70
▸ NSD1 Q96L73 1/20 0.70
▸ NSD3 Q9BZ95 1/20 0.70
▸ TMEM97 Q5BJF2 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26648473 1.00 BCL2 (0.83) BCL2BCL2L1MCL1BCL2L2NSD2
SCHEMBL31451050 0.96 BCL2 (0.82) BCL2BCL2L1MCL1BCL2L2NSD2
SCHEMBL26648671 0.96 BCL2 (0.82) BCL2BCL2L1MCL1BCL2L2NSD2
SCHEMBL26648341 0.95 BCL2 (0.84) BCL2
SCHEMBL31450990 0.95 BCL2 (0.84) BCL2
SCHEMBL31450972 0.94 BCL2 (0.82) BCL2
SCHEMBL26647909 0.94 BCL2 (0.82) BCL2
SCHEMBL31450898 0.92 BCL2 (0.81) BCL2
SCHEMBL31451009 0.92 BCL2 (0.81) BCL2
SCHEMBL26648300 0.92 BCL2 (0.81) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522154-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2025-03-19 — — EP disclosed
Send feedback